NewEdge Wealth LLC Purchases New Stake in National Health Investors, Inc. $NHI
NewEdge Wealth LLC has acquired a new stake of 29,178 shares, valued at $2.2 million, in National Health Investors, Inc. (NYSE:NHI) during the second quarter. Other institutional investors like BlackRock Inc. and State Street Corp also made significant moves in NHI stock. Despite several analyst downgrades, the stock currently holds a "Moderate Buy" consensus with an average price target of $83.86, and the company recently declared a $0.92 quarterly dividend, yielding 5.0%.
Is National Health Investors (NHI) Undervalued After Its Earnings And Dividend Update?
National Health Investors (NHI) recently reported higher Q2 2026 revenue and net income, along with a small dividend increase to $0.94 per share. While its 3-year shareholder return is strong, recent performance has been mixed. The company is considered 14.6% undervalued with an implied fair value of $85.75, based on long-term cash flows and increased demand in the senior housing market.
How Stronger Q2 Results And A Higher Dividend At National Health Investors (NHI) Has Changed Its Investment Story
National Health Investors (NHI) reported stronger Q2 2026 results with increased sales, revenue, net income, and EPS, leading to a modest dividend hike to US$0.94 per share. While these results bolster NHI's income-focused investment narrative, concerns about occupancy softness in senior housing persist. The company's future projections include significant revenue and earnings growth by 2029, suggesting an 18% upside to its current price according to fair value estimates.
National Health Investors (NHI) Could Be 11% Undervalued On Its New COO Appointment
National Health Investors (NHI) has appointed Chris Maingot as its new Chief Operating Officer, a move expected to enhance the company's focus on operational and portfolio experience. Despite a modest 1-day share price return, NHI's stock is considered undervalued with a fair value narrative suggesting an 11% upside. The company's expansion of its Senior Housing Operating Portfolio (SHOP) segment and projected double-digit NOI growth are key factors driving this optimistic outlook.
How Stronger Q2 Results And A Higher Dividend At National Health Investors (NHI) Has Changed Its Investment Story
National Health Investors (NHI) reported stronger-than-expected Q2 2026 results with increased sales, revenue, net income, and EPS, along with a raised quarterly dividend of US$0.94 per share. These positive financial outcomes and the dividend hike are seen as a boost to the company's income-focused investment thesis, despite ongoing concerns about occupancy softness in its senior housing operating portfolio. The article suggests that while the results are encouraging, investors should remain mindful of potential future challenges and consult various perspectives before making investment decisions.
National Health Investors, Inc. (NYSE:NHI) Receives Consensus Recommendation of "Moderate Buy" from Analysts
National Health Investors, Inc. (NYSE:NHI) has received a "Moderate Buy" consensus recommendation from eight brokerages, with an average 12-month price target of $83.86, significantly higher than its current share price of $71.23. The company also reported strong quarterly earnings of $1.19 EPS on $121.32 million in revenue and declared a quarterly dividend of $0.92 per share, yielding 5.2%. Insider buying activity, including purchases by the CEO and a director, indicates confidence in the company's future.
National Health Investors (NHI) Stock Price Sinks As SHOP Pivot Raises Doubts
National Health Investors (NHI) experienced a stock price drop after its Q2 2026 earnings release, with Funds From Operations (FFO) per share remaining broadly flat despite increased revenue and net income. The market reacted negatively to the company's pivot towards a senior housing operating portfolio (SHOP), which is perceived as higher risk due to mixed same-store results and concerns about execution. While the company maintains positive long-term prospects, the immediate market reaction indicates doubts about the SHOP strategy's de-risking.
National Health Investors, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:NHI) 2026-08-11
National Health Investors, Inc. (NHI) published its 2026 Q2 earnings call presentation. The company reported EPS of $1.15, missing estimates by $3.42, and revenue of $121.32M, beating estimates by $8.81M and showing a 33.81% year-over-year increase. This presentation is part of their official financial disclosures for the second quarter of 2026.
National Health Investors Inc (NHI) (Q2 2026) Earnings Call Highlights: Strategic Pivot to SHOP ...
National Health Investors Inc (NHI) reported Q2 2026 earnings, highlighting a strategic pivot towards its SHOP portfolio. The company significantly strengthened its balance sheet through asset sales and expanded its SHOP platform, despite a slight year-over-year decline in same-store SHOP NOI for legacy properties. NHI increased its quarterly dividend and is actively pursuing external growth, aiming to grow its SHOP assets to 40-50% of its total portfolio within three years.
National Health Investors Q2 Earnings Call Highlights
National Health Investors (NHI) reported Q2 results in line with expectations, driven by a significant portfolio sale and expansion of its seniors housing operating portfolio (SHOP). The company completed the sale of its NHC portfolio for $560 million, increasing its focus on private-pay senior housing and reducing leverage. NHI also saw increased net income and funds available for distribution, while continuing to grow its SHOP investments and evaluate new acquisition opportunities.
National Health Investors Q2 Earnings Call Highlights
National Health Investors (NHI) reported Q2 results in line with expectations, highlighted by the completion of a $560 million sale of its NHC portfolio, resulting in an anticipated $541.6 million gain in Q3. The company also saw a 5.8% increase in funds available for distribution, raised its quarterly dividend by $0.02 to $0.94 per share, and significantly grew its Seniors Housing Operating Portfolio (SHOP) investment by 137% year-over-year. NHI plans to further increase SHOP exposure to 40%-50% of its portfolio over the next three years while pursuing additional acquisitions.
National Health Investors earnings beat by $0.28, revenue fell short of estimates By Investing.com
National Health Investors (NYSE: NHI) reported Q2 EPS of $1.15, surpassing analyst estimates by $0.28, but revenue of $68.9M fell short of the consensus of $71.52M. The company's stock price has declined by 1.00% in the last three months and 1.47% in the past year, and its financial health is rated as "good performance" by InvestingPro.
National Health Investors: Q2 Earnings Snapshot
This article is a placeholder for National Health Investors' Q2 earnings snapshot. It currently contains no substantive content beyond its title and indicates that details will follow.
National Health Investors (NYSE: NHI) releases Q2 2026 investor update materials
National Health Investors (NHI) announced the release of its Q2 2026 investor update materials, including a presentation and a press release, accessible on its website. This information, furnished under Regulation FD, provides a business update for the second quarter of 2026. NHI, a self-managed REIT focused on senior housing and medical facilities, also included extensive forward-looking statements and directed investors to risk factor disclosures in its latest financial reports.
EDGAR Filing Documents for 0000877860-26-000201
This article provides details of an EDGAR 8-K filing (SEC Accession No. 0000877860-26-000201) by NATIONAL HEALTH INVESTORS INC. The filing, dated August 10, 2026, includes Regulation FD Disclosure and Financial Statements and Exhibits, along with interactive data and numerous graphic files. It also lists the company's mailing and business addresses and other identification details.
National Health Investors (NHI) outlines Q2 2026 NOI, lease mix and debt profile
National Health Investors (NHI) has furnished supplemental information for Q2 2026, detailing its senior housing and healthcare real estate portfolio and capital structure. The self-managed REIT reported an annualized adjusted Net Operating Income (NOI) of $289.0 million, with a diversified portfolio mix across senior housing, skilled nursing/hospital, and SHOP segments. The report also outlined lease maturities, capital structure, and non-GAAP financial measures like Adjusted EBITDA and FFO.
All eyes on National Health Investors earnings as revenue declines By Investing.com
National Health Investors Inc. is set to report its second-quarter earnings, with analysts anticipating a 10% EPS increase year-over-year but a 22% decline in revenue. Investors will be closely watching whether the revenue contraction is due to strategic portfolio repositioning or operational challenges, especially given the strong overall market for senior housing. The company has made recent strategic moves, including acquisitions and a shift towards private-pay senior housing, which will be assessed against its performance in this transitional period.
Bank of America Corp DE Purchases 165,467 Shares of National Health Investors, Inc. $NHI
Bank of America Corp DE increased its stake in National Health Investors (NYSE:NHI) by 20% in the first quarter, acquiring an additional 165,467 shares to bring its total holdings to 992,802 shares valued at approximately $80.3 million. This purchase, along with other institutional activity and recent insider buying by Director Robert McCabe and CEO D. Eric Mendelsohn, highlights continued interest in the healthcare REIT. Despite a "Moderate Buy" consensus rating from analysts, some brokerages have recently adjusted their price targets downward.
Renaissance Technologies LLC Invests $3.37 Million in National Health Investors, Inc. $NHI
Renaissance Technologies LLC has initiated a new position in National Health Investors (NYSE:NHI), acquiring 41,699 shares valued at approximately $3.37 million, representing about 0.09% of the healthcare REIT. Institutional ownership of NHI stands at 62.51%, with recent insider buying from CEO D. Eric Mendelsohn and Director Robert A. McCabe Jr., bringing insider ownership to 2.70%. Analysts currently have a "Moderate Buy" rating for NHI, with an average price target of $83.86 compared to the stock's $75.40 opening price.
NATIONAL HEALTH INVESTORS Q2 2026 Earnings Preview: Recent $NHI Insider Trading, Hedge Fund Activity, and More
NATIONAL HEALTH INVESTORS (NHI) is set to release its Q2 2026 earnings on August 10th, with analysts projecting $112.8 million in revenue and $0.86 EPS. Recent insider activity shows two purchases in the last six months, totaling over $160,000, while institutional investors have shown mixed sentiment, with BlackRock significantly increasing its stake. The median analyst price target for NHI is $80.0.
The Bull Case For National Health Investors (NHI) Could Change Following Appointment Of Veteran COO Chris Maingot
National Health Investors (NHI) recently appointed Chris Maingot, a veteran in senior housing leadership, as its Chief Operating Officer. This strategic hire is expected to influence NHI's management of senior housing assets and growth initiatives, particularly as the company focuses on operational performance and portfolio optimization. Investors will be keen to observe how Maingot's expertise impacts occupancy stabilization, acquisition timing, and operator relationships, especially with the upcoming Q2 2026 earnings release.
State Street (NHI holder) discloses 2.74M National Health Investors shares in 13G
State Street Corporation has filed a Schedule 13G, disclosing a beneficial ownership of 2,735,937 shares of National Health Investors, Inc. (NHI) common stock, which represents a 5.6% stake in the company as of June 30, 2026. The filing indicates that State Street exercises shared voting power over 2,454,990 shares and shared dispositive power over all 2,735,937 shares through its affiliated investment adviser subsidiaries. This disclosure highlights State Street's significant passive investment in National Health Investors.
Lazard Asset Management LLC Makes New Investment in National Health Investors, Inc. $NHI
Lazard Asset Management LLC has made a new investment in National Health Investors, Inc. (NYSE:NHI), purchasing 18,012 shares valued at approximately $1.46 million. This investment comes as institutional investors collectively own 62.51% of the REIT, and company insiders have also increased their holdings. Despite some recent analyst downgrades, the company holds a consensus "Moderate Buy" rating with an average price target of $83.86.
ETFs Investing in National Health Investors, Inc. Stocks
This article lists various Exchange Traded Funds (ETFs) that hold stocks of National Health Investors, Inc. The ETFs are sorted by market value and include details such as weight, issuer, management style, focus, expense ratio, AUM, price change, and 3-year NAV total return. The information aims to help investors find opportunities with lower risk in the small-cap and real estate sectors.
Militia Capital Management LLC Purchases New Holdings in National Health Investors, Inc. $NHI
Militia Capital Management LLC has acquired a new position in National Health Investors (NHI), purchasing 30,400 shares valued at approximately $2.46 million. This move is part of broader institutional investment, with various firms increasing their holdings in NHI, which is a real estate investment trust focused on healthcare and senior housing facilities. Despite some recent target price reductions, analysts generally maintain a "Moderate Buy" rating for NHI, with an average price target of $83.86.
National Health Investors (NHI) Expected to Release Quarterly Earnings on Monday
National Health Investors (NHI) is scheduled to release its Q2 2026 earnings on Monday, August 10th, with analysts forecasting earnings per share of $0.843 and revenue of $72.1 million. The stock opened at $76.81, below the consensus price target of $83.86, despite a "Moderate Buy" rating from analysts. Recent insider buying by Director Robert McCabe and CEO D. Eric Mendelsohn, along with significant institutional ownership, are also highlighted.
Edgestream Partners L.P. Sells 18,349 Shares of National Health Investors, Inc. $NHI
Edgestream Partners L.P. significantly reduced its stake in National Health Investors (NYSE:NHI) by 39.5%, selling 18,349 shares and retaining 28,101 shares valued at $2.27 million. Despite the sale, institutional investors collectively own 62.51% of NHI, and analyst sentiment remains a "Moderate Buy" with an average price target of $83.86. The article also notes recent insider buying by NHI's CEO and a Director, totaling approximately $167,000.
Dimensional Fund Advisors LP Grows Stock Holdings in National Health Investors, Inc. $NHI
Dimensional Fund Advisors LP increased its stake in National Health Investors, Inc. (NHI) by 2.7% in the first quarter, now holding 686,249 shares valued at $55.5 million. Institutional investors own 62.51% of NHI, which also saw share purchases by company insiders including its CEO. Despite recent price target cuts, analysts maintain a "Moderate Buy" consensus rating for NHI, with an average price target of $83.86, and the company recently declared a quarterly dividend of $0.92 per share.
(NHI) as a Liquidity Pulse for Institutional Tactics
This article analyzes National Health Investors Inc. (NYSE: NHI) using AI models to provide institutional trading strategies. It highlights conflicting sentiment, a mid-channel oscillation pattern, and an exceptional risk-reward short setup. The analysis includes position trading, momentum breakout, and risk hedging strategies, along with multi-timeframe signal analysis.
National Health Investors (NYSE: NHI) awards COO 2,370 restricted shares
National Health Investors (NYSE: NHI) has awarded its Chief Operating Officer, Christian Ken Maingot, 2,370 shares of restricted common stock. This grant, made on July 27, 2026, vests in three equal annual installments starting July 27, 2027, provided his continued service to the company. Following this transaction, Mr. Maingot's direct holdings in NHI total 2,370 shares.
National Health Investors (NYSE: NHI) COO submits initial Form 3
National Health Investors Inc.'s Chief Operating Officer, Christian Ken Maingot, has filed an initial Form 3, an "Initial Statement of Beneficial Ownership." This filing indicates his position as COO but shows no reportable non-derivative or derivative securities currently owned by him, establishing a baseline for future insider ownership reports. The document clarifies the role of a COO and details the regulatory implications of the filing for investors and the company's management.
What National Health Investors (NHI)'s New COO Appointment Means For Shareholders
National Health Investors (NHI) has appointed Chris Maingot as Chief Operating Officer, a move seen as aligning with the company's priorities in senior housing. Maingot's 20 years of experience in senior housing is expected to influence NHI's portfolio optimization and capital allocation, particularly as the company focuses on stabilizing occupancy and managing operator risk. Investors are keenly awaiting NHI's Q2 2026 earnings release to assess how these operational changes will impact its performance and outlook.
National Health Investors Appoints First Chief Operating Officer
National Health Investors (NHI) has appointed Christian (Chris) Maingot as its first Chief Operating Officer, a move intended to bolster its operational strength and expand its senior housing portfolio. Maingot brings over two decades of senior housing experience, including leadership roles at Longview Senior Housing and Brookdale Senior Living. The appointment comes as NHI aims for long-term growth and deeper engagement with operating partners, with the stock currently holding a "Hold" rating from analysts and an "Outperform" assessment from TipRanks’ AI Analyst, Spark.
NHI Appoints Chris Maingot as Chief Operating Officer
National Health Investors, Inc. (NHI) has appointed Chris Maingot as its first Chief Operating Officer, effective July 27, 2026. This move aims to enhance NHI's long-term growth by expanding its senior housing portfolio and strengthening operating relationships. Maingot brings over 20 years of experience in senior housing, previously serving as CEO of Longview Senior Housing and holding leadership roles at Brookdale Senior Living.
Press Release: NHI Appoints Chris Maingot as Chief Operating Officer
NHI (National Health Investors) has announced the appointment of Chris Maingot as its new Chief Operating Officer, effective August 12, 2024. Maingot joins NHI with over two decades of extensive leadership experience in healthcare operations and finance, including significant roles at Welltower and other senior living organizations. His expertise is expected to enhance NHI's operational strategies and support its growth initiatives within the senior housing and healthcare real estate sectors.
National Health Investors Appoints Chris Maingot as First Chief Operating Officer to Drive Senior Housing Growth
National Health Investors (NHI) has appointed Chris Maingot as its first Chief Operating Officer (COO), a move signaling the company's commitment to strengthening its operational capacity and expanding its senior housing portfolio. Maingot brings over 20 years of experience in senior housing operations and portfolio management, previously serving as CEO of Longview Senior Housing and holding leadership roles at Brookdale Senior Living. His appointment is expected to enhance NHI's growth strategy, improve operational efficiency, and deepen relationships with key partners, potentially boosting investor confidence and financial performance.
New COO for National Health Investors (NYSE: NHI) to lead operations
National Health Investors, Inc. (NHI) has appointed Christian “Chris” Maingot as its first Chief Operating Officer, effective July 27, 2026. Maingot, with over 20 years of senior housing experience, will receive an initial annual base salary of $415,000, along with performance-based cash incentives and equity awards. This strategic move aims to strengthen NHI’s operating platform and support the growth of its senior housing portfolio.
What National Health Investors (NHI)'s New COO Appointment Means For Shareholders
National Health Investors (NHI) has appointed Chris Maingot as its new Chief Operating Officer, bringing over 20 years of senior housing experience. His expertise in portfolio optimization and capital deployment is expected to influence NHI's senior housing operating portfolio and capital allocation strategies. While the appointment aligns with NHI's priorities of managing SHOP exposure and tenant risk, the immediate focus remains on stabilizing occupancy, with the upcoming Q2 2026 earnings release providing key insights.
NHI Appoints Chris Maingot as Chief Operating Officer
National Health Investors, Inc. (NHI) has appointed Chris Maingot as Chief Operating Officer, effective July 27, 2026. Maingot brings over 20 years of senior housing experience, including leadership roles at Longview Senior Housing and Brookdale Senior Living. This appointment aims to enhance NHI's growth capabilities, strengthen its operating platform, and capitalize on opportunities in the senior housing market.
National Health Investors, Inc. $NHI Shares Sold by Bank of New York Mellon Corp
Bank of New York Mellon Corp reduced its stake in National Health Investors (NHI) by 4.2% in the first quarter, selling 22,500 shares. Despite this, other institutional investors increased their holdings, and company insiders, including CEO D. Eric Mendelsohn and Director Robert A. McCabe Jr., purchased shares. Analyst sentiment is mixed, with a consensus "Moderate Buy" rating, and NHI recently announced a quarterly dividend of $0.92 per share.
National Health Investors, Inc. Revenue Breakdown – NYSE:NHI
National Health Investors, Inc. (NYSE: NHI) generated $271.60 million in total revenue last year, with its Real Estate Investments segment being the highest contributor at $295.57 million. The majority of the company's revenue, $375.63 million, originated from the United States. This indicates a strong performance in its core real estate segment and significant reliance on the U.S. market.
Is National Health Investors (NHI) Undervalued As Its Share Price Nears Fair Value?
National Health Investors (NHI) has shown recent strong share price performance and holds a fair value estimate of $85.75 against its current price of $81.10, indicating it is approximately 5.4% undervalued. This valuation is largely driven by its SHOP segment growth and potential accretive acquisitions. However, the company faces execution risks in its senior housing operating portfolio and tenant concentration concerns, with its P/E ratio higher than the industry average but below a suggested fair ratio, presenting a mixed outlook for investors.
Militia Capital Management LLC Makes New $2.46 Million Investment in National Health Investors, Inc. $NHI
Militia Capital Management LLC has made a new investment of $2.46 million in National Health Investors, Inc. (NYSE:NHI) by acquiring 30,400 shares in the first quarter. This makes Militia Capital Management LLC own about 0.06% of the company's stock. Other institutional investors also adjusted their holdings, and the stock currently has a consensus "Moderate Buy" rating from analysts with an average price target of $83.86.
NHI stock trades below recent highs as healthcare REIT focuses on portfolio transitions
National Health Investors (NHI) stock is trading below recent highs as the healthcare REIT undergoes a portfolio reshaping, focusing on senior housing communities despite facing pressure on rental income in 2023. The company reported a modest revenue decline and slightly lower FFO, but has shown improved tenant coverage ratios and is strategically deleveraging. NHI aims to stabilize cash flows and enhance tenant credit quality by shifting its portfolio towards private-pay senior housing, maintaining a substantial dividend for income-focused investors.
NHI to sell healthcare property portfolio to NHC for $560M
NHI plans to sell a portfolio of healthcare properties to NHC for $560 million. This strategic sale will likely impact the financial positions and operational focus of both companies.
National Health Investors, Inc. (NYSE:NHI) Receives Average Rating of "Moderate Buy" from Analysts
MarketBeat reports that National Health Investors, Inc. (NYSE:NHI) has received a consensus "Moderate Buy" rating from analysts, with an average 12-month target price of $83.8571. Recent analyst reports show mixed recommendations, including downgrades and price target adjustments. Insider buying activity by the company's director and CEO, along with institutional investor movements, are also highlighted in the report.
(NHI) Risk Channels and Responsive Allocation
This article from Stock Traders Daily provides an AI-generated analysis for National Health Investors Inc. (NYSE: NHI), highlighting strong near-term sentiment with neutral mid and long-term outlooks. It details specific trading strategies including Position, Momentum Breakout, and Risk Hedging, along with multi-timeframe signal analysis indicating support and resistance levels. The report emphasizes a favorable 30.1:1 risk-reward setup targeting an 8.8% gain against 0.3% risk.
NHI to sell healthcare property portfolio to NHC for $560M
NHI is set to sell a healthcare property portfolio to NHC for $560 million. This significant transaction involves the transfer of multiple healthcare assets between the two companies.
Forty three Eighteen Advisors LLC Acquires New Shares in National Health Investors, Inc. $NHI
Forty three Eighteen Advisors LLC has acquired new shares in National Health Investors, Inc. (NYSE:NHI), purchasing 24,791 shares valued at approximately $2.0 million in the first quarter. This move makes NHI the 18th largest holding for the firm, representing 1.5% of its investment portfolio. Other institutional investors and company insiders have also increased their stakes in NHI, contributing to 62.51% institutional ownership, and analysts maintain a "Moderate Buy" rating with a price target of $83.86.
NHI stock holds as National Health Investors reports steady rent coverage
National Health Investors (NHI) stock remains stable, driven by reported rent coverage and a consistent dividend track record. The company, a REIT focusing on healthcare properties like senior housing and assisted living, emphasizes recurring rental cash flow and portfolio stability as key investment metrics. The article highlights that for income-focused investors, the focus is on operating and payout metrics rather than short-term market movements.
